Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Huber

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Molecular and Cellular Biology|February 1, 1993
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 proteinP S Huang, D R Patrick, G Edwards, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Transcription factor E2F binds DNA as a heterodimerH E Huber, G Edwards, P J Goodhart, et al.
The Journal of Biological Chemistry|January 15, 1992
Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor proteinR E Jones, D C Heimbrook, H E Huber, et al.
The Journal of Antibiotics|March 1, 2000
Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEKA Zhao, S H Lee, M Mojena, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Journal of the American Chemical Society|July 18, 2001
Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferaseC J Dinsmore, M J Bogusky, J C Culberson, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular and Cellular Biology|February 1, 1993
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 proteinP S Huang, D R Patrick, G Edwards, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Transcription factor E2F binds DNA as a heterodimerH E Huber, G Edwards, P J Goodhart, et al.
The Journal of Biological Chemistry|January 15, 1992
Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor proteinR E Jones, D C Heimbrook, H E Huber, et al.
The Journal of Antibiotics|March 1, 2000
Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEKA Zhao, S H Lee, M Mojena, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Journal of the American Chemical Society|July 18, 2001
Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferaseC J Dinsmore, M J Bogusky, J C Culberson, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Pageof 3